First, hypoxia‐triggered release of chemoattractants (i.e., CCL2, CCL5, CXCL12, CSF‐1, and VEGF) from tumor cells and non‐tumor cells to enhance TAMs precursor monocytes recruitment. This evidence concerns the gene CCL2 and neoplasm.